40
Views
4
CrossRef citations to date
0
Altmetric
Research Article

CD4+CD56+ Neoplasia: Clinical and Biological Features with Emphasis on Cytotoxic Drug-induced Apoptosis and Expression of Sialyl Lewis X

, , , , , , , & show all
Pages 281-289 | Published online: 01 Jul 2009

  • Nakamura, S., Suchi, T., Koshikawa, T., Kitoh, K., Koike, K., Komatsu, H., Iida, S., Kagami, Y., Ogura, M., Katoh, E., Kurita, S., Suzuki, H., Kobashi, Y., Yamabe, H., Hirabayashi, N., Ueda, R. and Takahashani, T. (1995) "Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract", American Journal of Surgical Pathology 19, 284-296.
  • Suzuki, R. and Nakamura, S. (1999) "Malignancies of natural killer (NK) cell precursor. Myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia", Leukemia Research 23, 615-624.
  • Adachi, M., Maeda, K., Takekawa, M., Hinoda, Y., Imai, K., Sugiyama, A. and Yachi, A. (1994) "High expression of CD56 (N-CAM) in patient with cutaneous CD4-positive lymphoma", American Journal of Hematology 47, 278-282.
  • DiGiuseppe, J.A., Louie. D.C., Williams, J.E., Miller, D.T., Griffin, C.A., Mann, R.B. and Borowitz, M.J. (1997) "Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study'', American Journal of Surgical Pathology 21(10), 1223-1230.
  • Kimura, A., Kakazu, N., Kuroda, J., Akagoigi, T., Hayashi, H., Nishida, K. and Abe, T. (2001) "Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma", Annals of Hematology 80, 228-231.
  • Groupe Français d'Etude des Lymphomes Cutané (GFELC) Petrella, T., Dalac, S., MaynadiU+00+E9, M., Mugneret, F., Thomine, E., Courville, P., Joly, P., Lenormand, B., Arnould, L, Wechsler, J., Bagot, M., Rieux, C., Bosq, J., Avril, M.-F., Bernheim, A., Molina, T., Devidas, A., Delfrau-Larue, M.-H., Gaulard, P. and Lambert, D. (1999) "CD4+ CD56+ cutaneous neoplasm: a distinct hematological enitity?", American Journal of Surgical Pathology 23(2), 137-146.
  • Feuillard, J., Jacob, M.-C., Valensi, F., Maynadié, M., Gressin, R., Chaperot, L., Arnoulet, C., Brignole-Baudouin, F., Drénou, B., Duchayne, E., Falkenrodt, A., Garand, R., Hormolle, E., Husson, B., Kuhlein, K., Le Calvez, G., Dainty, D., Sotto. M.-F., Trimoreau, F. and Béné, M.-C. (2001) "Clinical and biological features of CD4+CD56+ malignancies", Blood 99, 1556-1563.
  • Chan, J.K.C., Jaffe, E.S. and Ralfkiaer, E. (2001) "Blastic NK-cell lymphoma", In: Jaffe, E.S., Harris, N.L., Stein, H. and Vardiman, J.W., eds. Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon, France), pp 214-215.
  • Chaperot, L., Bendriss, N., Manches, O., Gressin, R., Maynadie, M., Trimoreau, F., Orfeuvre, H., Corront, B., Feuillard, J., Sotto, J.-J., Bensa, J.-C., Brière, F., Plumas, J. and Jacob, M.-C. (2001) "Identification of a leukemic counterpart of the plasmacytoid dendritic cells", Blood 97, 3210-3217.
  • Robertson, M.J. and Ritz, J. (1990) "Biology and clinical relevance of natural killer cells", Blood 76, 2421-2438.
  • Group Français de Cytogénétique HématologiqueLeroux, D., Mugneret, F., Callanan, M., Radford-Weiss, I., Dastugue, N., Feuillard, J., Le Mée, F., Plessis, G., Talmant, P., Gachard, N., Uetwiller, F., Pages, M.-P., Mozziconacci, M.-J., Eclache, V., Sibille, C., Avet-Loiseau, H., and Lafage-Pochitaloff, M. (2002) "CD4+, CD56+ DC acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Group Français de Cytogénétique Hématologique", Blood 99, 4154-4159.
  • Rummel, M.J., Chow, K.U., Karakas, T., Jaeger, E., Mezger, J., Kaefer, G., Boehrer, S., Bergmann, L., Martin, H., Hoelzer, D. and Mitrou, P.S. (1999) "Cladribine (2-chlorodeoxyadenosine, 2-CdA) plus mitoxantrone in the treatment of progressive advanced low-grade non-Hodgkin's and mantle cell lymphomas. Preliminary results of a phase-II study. [abstract]", Blood 94(Suppl. 1), 2931.
  • Spieker, T. and Herbst, H. (2000) "Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease". American Journal of Pathology 157, 51-57.
  • Muche, J.M., Lukowsky, A., Asadullah, K., Gellrich, S. and Sterry, W. (1997) "Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T cell lymphoma", Blood 90, 1636-1642.
  • Duijivestijn, A.M., Horst, E., Pals, S.T., Rouse, B.N., Steere, A.C., Picker, L.C., Meijer, C.J.L.M. and Butcher, E. (1988) "High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452", The American Journal of Pathology 130, 147-155.
  • Zollner, T.M., Podda, M., Pien, C., Elliott, P.J., Kaufmann, R. and Boehncke, W.H. (2002) "Proteasome inhibition reduces super-antigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model", Journal of Clinical Investigation 109, 671-679.
  • Schui, D.K., Singh, L., Schneider, B., Knau, A., Hoelzer, D. and Weidmann, E. (2002) "Inhibiting effects on the induction of cytotoxic T lymphocytes by dendritic cells pulsed with lysates from acute myeloid leukemia blasts", Leukemia Research 26, 383-389.
  • Chow, K.U., Ries, J., Weidmann, E., Pourebrahim, F., Napieralski, S., Stieler, M., Boehrer, S., Rummel, M.J., Stein, J., Hoelzer, D. and Mitrou, P.S. (2000) "Induction of apoptosis using 2' 2' difluorodeoxycytidine (gemcitabine) in combination with antimetabolits or anthracyclines on malignant lymphatic and myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells", Annals of Hematology 79(9), 485-492.
  • Chow, K.U., Rummel, M.J., Weidmann, E., Ries, J., Jantschke, P., Boehrer, S., Pourebrahim, F., Napieralski, S., Stein, J., Martin, H., Hoelzer, D. and Mitrou, P.S. (2000) "Induction of apoptosis by 2-Choloro-2'deoxyadenosine (2-CdA) alone and in combination with other cytotoxic drugs: synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone", Leukemia and Lymphoma 36(5-6), 559-567.
  • Jaffe, H.S., Harris, N.L., Stein, H. and Vardima, J.W. (2001) World Health Organization Classification of Tumors: Tumors of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon, France).
  • Brody, J.P., Allen, S., Schulman, P., Sun, T., Chan, W.C., Friedmann, H.D., Teichberg, S., Koduru, P., Cone, R.W. and Loughran, Jr, T.P. (1994) "Acute agranular CD4-positive natural killer cell leukemia", Cancer 75, 2474.
  • Kobashi, Y., Nakamura, S., Sasajima, Y., Koshikawa, T., Yatabe, Y., Kitoh, K., Mori, S., Yamabe, H. and Suchi, T. (1996) "Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other that the upper and lower respiratory tract", Histopathology 28, 111-120.
  • Chan, J.K.C., Sin, V.C., Wong, K.F., Ng, C.S., Tsang, W.Y., Chan, C.H., Cheung, M.M. and Lau, W.H. (1997) "Non-nasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm", Blood 89, 4501-4513.
  • Yamada, 0., Ichikawa, M., Okamoto, T., Park, C., Motoji, T., Miuzogushi, H. and Shibuya, A. (2001) "Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukemia: implication for successful treatment and possible therapeutic strategies", British Journal of Haematology 113, 153-160.
  • Ichinoshasama, R., Endoh, K., Ishizawa, K., Okuda, M., Kameoka, J., Meguro, K., Myers, J., Kadin, M.E., Mori, S. and Sawai, T. (1996) "Thymic lymphoblastic lymphoma of committed natural killer cell precursor origin: a case report", Cancer 77, 2592-2603.
  • Scott, A.A., Head, D.R., Kopecky, K.J., Appelbaum, F.R., Theil, K.S., Grever, M.R., Chen, I.M., Whittaker, M.H., Griffith, B.B., Licht, J.D., Waxman, S., Whalen, M.M., Bankhurst, A.D., Richter, L.C., Grogan, T.M. and Willman, C.L. (1994) "HLA-DR- CD 33+ CD 56-, CD 16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3", Blood 84, 244-255.
  • Rakozy, C.K., Mohamed, A.N., Vo, T.D., Khatib, G., Long, P.M., Eilender, D. and Palutke, M. (2001) "CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, and clinically diverse", American Journal of Clinical Pathology 116, 168-176.
  • Bayerl, M.G., Rakozy, C.K., Mohamed, A.N., Vo, T.D., Long, M., Eilender, D. and Palutke, M. (2002) "Blastic natural killer cell lymphoma/leukemia: report of seven cases", American Journal of Clinical Pathology 117, 41-50.
  • Dummer, R., Potoczna, N., Häffner, A.C., Zimmermann, D.R., Gilardi, S. and Burg, G. (1996) "A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma". Archives of Dermatology 132, 550-553.
  • Kameoka, J., Ichinohasama, R., Tanaka, M., Miura, I., Tomiya, Y., Takahashi, S., Yamada, M., Ishikawa, I., Kadowaki, I., Sasaki, O., Kimura, J., Meguro, K., Ooya, K. and Ito, S. (1998) "A cutaneous agranular CD2- CD4+ CD56+ 'Lymphoma'", Hematopathology 110, 478-488.
  • Ikushima, S., Yoshihara, T., Matsumura, T., Misawa, S., Morioka, Y., Hibi, S. and Imashuku, S. (1991) "Expression of CD56/NCAM on hematopoeitic malignant cells. A useful marker for acute monocytic and megacaryocytic leukemias", International Journal of Hematology 54, 395-403.
  • Tauchi, T., Ohyashiki, K., Ohyashiki, J.H., Kawanashi, Y., Kimura, Y., Saito, M., Nakazawa, S., Kawai, Y. and Toyama, K. (1990) "CD4+ and CD56+ acute monoblastic leukemia", American Journal of Hematology 34, 228-229.
  • Suzuki, R., Yamamoto, K., Seto, M., Kagami, Y., Ogura, M., Yatabe, Y., Suchi, T., Kodera, Y., Morishima, Y., Takashi, T., Saito, H., Ueda, R. and Nakamura, S. (1997) "DC7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hemato-lymphoid disease entity", Blood 90, 2417-2428.
  • Kojima, H., Mukai, H.Y., Shinagawa, A., Yoshida, C., Kamoshita, M., Komeno, T., Hasegawa, Y., Yamashita, Y., Mori, N. and Nagasawa, T. (2000) "Clinicopathological analyses of 5 Japanese patients with CD56+ primary cutaneous lymphomas", International Journal of Hematology 72, 477-483.
  • Kawano, S., Tatsumi, E. and Yoneda, N. (1995) "Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient", Hematology Oncology 13, 1.
  • Koita, H., Suzumiya, J., Oshima, K., Takeshita, M., Kimura, N., Kikuchi, M. and Koono, M. (1997) "Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity", American Journal of Surgical Pathology 21, 242.
  • Nakamura, S., Koshikawa, T., Yatabe, Y. and Suchi, T. (1998) "Lymphoblastic lymphoma expressing CD56 and TdT", American Journal of Surgical Pathology 22(I), 135-137.
  • Berg, E.L., Yoshino, T. and Rott, L.S. (1991) "The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1", Journal of Experimental Medicine 174, 1461-1466.
  • Rappl, G., Muche, J.M., Abken, H., Sterry, W., Tilgen, W., Ugurel, S. and Reinhold, U. (2001) "CD4(+) CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome", Journal of the American Academy of Dermatology 44, 456-461.
  • Scala, E., Russo, G., Cadoni, S., Narducci, M.G., Girardelli, C.R., De Pita, E. and Puddu, P. (1999) "Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion", Journal of Investigative Dermatology 113, 622-627.
  • Fuhlbrigge, R.C., Kieffer, J.D., Armerding, D. and Kupper, T.S. (1997) "Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells", Nature 389, 978-981.
  • Tietz, W., Allemand, Y., Borges, E., von Laer, D., Hallmann, R., Vestweber, D. and Hamann, A. (1998) "CD4+ T cells migrated into inflamed skin only if they express ligands for E- and P-selectin", Journal of Immunology 161, 963-970.
  • Munro, J.M., Lo, S.K., Corless, C., Robertson. M.J., Lee, N.C., Barnhill, R.L., Weinberg, D.S., and Bevilacqua, M.P. (1992) "Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues", American Journal of Pathology 141, 1397-1408.
  • Baraczka, K., Nekam, K., Pozsonyi, T., Jakab, L., Szongoth, M. and Sesztak, M. (2000) "Concentration of soluble adhesion molecules (cVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement", Neuroimmunomodulation 9, 49-54.
  • Grewal, I.S., Foellmer, H.G., Grewal, K.D., Wang, H., Lee, W.P., Tumas, D., Janeway, Jr., C.A. and Flavell, R.A. (2001) "CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis", Immunity 14, 291-302.
  • Vergelli, M., Le, H., van Nnoort, J.M., Dhib-Jalbut, S., McFarland, H. and Martin, R. (1996) "A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule", Journal of Immunology 157, 679-688.
  • Nagatani, T., Okazawa, H., Kambara, T., Satoh, K., Tokura, H., Miyazawa, M., Yamada, R., Baba, N., Nakajima, H., Yamakazaki, E., Kanamori, H. and Mohri, H. (2000) "Cutaneous monomorphous CD4- and CD56- positive large-cell lymphoma", Dermatology 200, 202-208.
  • Bagot, M., Bouloc, A., Charue, D., Wechsler, J., Bensussan, A. and Boumsell, L. (1998), Journal of Investigative Dermatology 111, 1242-1243.
  • Uchiyama, N., Ito, K., Kawai, K., Sakamoto, F., Takaki, M. and Ito, M. (1998) "CD2- CD4+, CD56+ agranular natural killer cell lymphoma of the skin", American Journal of Dermatopathology 20, 513-517.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.